REVLIMID for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where REVLIMID was used for Off label use.
Most Reported Side Effects for REVLIMID
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pneumonia | 652 | 7.3% | 85 | 589 |
| Plasma cell myeloma | 632 | 7.1% | 241 | 184 |
| Death | 565 | 6.4% | 564 | 51 |
| Diarrhoea | 508 | 5.7% | 20 | 207 |
| Thrombosis | 484 | 5.5% | 4 | 165 |
| Fatigue | 448 | 5.1% | 17 | 149 |
| Platelet count decreased | 362 | 4.1% | 9 | 112 |
| Full blood count decreased | 352 | 4.0% | 6 | 172 |
| Deep vein thrombosis | 332 | 3.7% | 6 | 154 |
| Pancytopenia | 319 | 3.6% | 20 | 91 |
| Rash | 310 | 3.5% | 11 | 88 |
| Anaemia | 286 | 3.2% | 28 | 145 |
| White blood cell count decreased | 284 | 3.2% | 4 | 102 |
| Neutropenia | 253 | 2.9% | 33 | 93 |
| Asthenia | 239 | 2.7% | 17 | 136 |
Other Indications for REVLIMID
Plasma cell myeloma (7,122)
Myelodysplastic syndrome (835)
Chronic lymphocytic leukaemia (121)
Lymphoma (121)
Product used for unknown indication (90)
Mantle cell lymphoma (76)
5q minus syndrome (72)
Acute myeloid leukaemia (56)
Amyloidosis (56)
Myelofibrosis (52)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)